{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:47:00Z","timestamp":1793731620952,"version":"4.6.1"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T00:00:00Z","timestamp":1705622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Genomics PLC"},{"DOI":"10.13039\/100030827","name":"NHS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030827","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>The aim of the study was to assess the real-world feasibility, acceptability, and impact of an integrated risk tool for cardiovascular disease (CVD IRT, combining the standard QRISK\u00ae2 risk algorithm with a polygenic risk score), implemented within routine primary practice in the UK National Health Service.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>The Healthcare Evaluation of Absolute Risk Testing Study (NCT05294419) evaluated participants undergoing primary care health checks. Both QRISK2 and CVD IRT scores were returned to the healthcare providers (HCPs), who then communicated the results to participants. The primary outcome of the study was feasibility of CVD IRT implementation. Secondary outcomes included changes in CVD risk (QRISK2 vs. CVD IRT) and impact of the CVD IRT on clinical decision-making. A total of 832 eligible participants (median age 55 years, 62% females, 97.5% White ethnicity) were enrolled across 12 UK primary care practices. Cardiovascular disease IRT scores were obtained on 100% of the blood samples. Healthcare providers stated that the CVD IRT could be incorporated into routine primary care in a straightforward manner in 90.7% of reports. Participants stated they were \u2018likely\u2019 or \u2018very likely\u2019 to recommend the use of this test to their family or friends in 86.9% of reports. Participants stated that the test was personally useful (98.8%) and that the results were easy to understand (94.6%). When CVD IRT exceeded QRISK2, HCPs planned changes in management for 108\/388 (27.8%) of participants and 47% (62\/132) of participants with absolute risk score changes of &amp;gt;2%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Amongst HCPs and participants who agreed to the trial of genetic data for refinement of clinical risk prediction in primary care, we observed that CVD IRT implementation was feasible and well accepted. The CVD IRT results were associated with planned changes in prevention strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurjpc\/zwae004","type":"journal-article","created":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T08:32:31Z","timestamp":1705307551000},"page":"716-722","source":"Crossref","is-referenced-by-count":50,"title":["A polygenic risk score added to a QRISK\u00ae2 cardiovascular disease risk calculator demonstrated robust clinical acceptance and clinical utility in the primary care setting"],"prefix":"10.1093","volume":"31","author":[{"given":"Ahmet","family":"Fuat","sequence":"first","affiliation":[{"name":"Durham University , Durham , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella","family":"Adlen","sequence":"additional","affiliation":[{"name":"Genomics plc , King Charles House, Park End Street, Oxford OX1 1JD , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Monane","sequence":"additional","affiliation":[{"name":"Genomics plc , King Charles House, Park End Street, Oxford OX1 1JD , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Coll","sequence":"additional","affiliation":[{"name":"Genomics plc , King Charles House, Park End Street, Oxford OX1 1JD , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Groves","sequence":"additional","affiliation":[{"name":"Genomics plc , King Charles House, Park End Street, Oxford OX1 1JD , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Little","sequence":"additional","affiliation":[{"name":"Wellspring Medical Practice , Newcastle upon Tyne , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Wild","sequence":"additional","affiliation":[{"name":"Pelton and Fellrose Medical Group , Pelton , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzan J","family":"Kamali","sequence":"additional","affiliation":[{"name":"Hadrian Primary Care Alliance , Stocksfield , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf","family":"Soni","sequence":"additional","affiliation":[{"name":"Riverside General Practice , Stockton-on-Tees , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shona","family":"Haining","sequence":"additional","affiliation":[{"name":"Research and Evidence, NHS North of England Commissioning Support , Durham , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Riding","sequence":"additional","affiliation":[{"name":"Research and Evidence, NHS North of England Commissioning Support , Durham , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Riveros-Mckay","sequence":"additional","affiliation":[{"name":"Genomics plc , King Charles House, Park End Street, Oxford OX1 1JD , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iliana","family":"Peneva","sequence":"additional","affiliation":[{"name":"Genomics plc , King Charles House, Park End Street, Oxford OX1 1JD , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Lachapelle","sequence":"additional","affiliation":[{"name":"Genomics plc , King Charles House, Park End Street, Oxford OX1 1JD , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Giner-Delgado","sequence":"additional","affiliation":[{"name":"Genomics plc , King Charles House, Park End Street, Oxford OX1 1JD , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E","family":"Weale","sequence":"additional","affiliation":[{"name":"Genomics plc , King Charles House, Park End Street, Oxford OX1 1JD , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Plagnol","sequence":"additional","affiliation":[{"name":"Genomics plc , King Charles House, Park End Street, Oxford OX1 1JD , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0973-3557","authenticated-orcid":false,"given":"Seamus","family":"Harrison","sequence":"additional","affiliation":[{"name":"Genomics plc , King Charles House, Park End Street, Oxford OX1 1JD , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Donnelly","sequence":"additional","affiliation":[{"name":"Genomics plc , King Charles House, Park End Street, Oxford OX1 1JD , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,1,19]]},"reference":[{"key":"2024041812175402100_zwae004-B1","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","article-title":"Heart disease and stroke statistics\u20142022 update: a report from the American Heart Association","volume":"145","author":"Tsao","year":"2022","journal-title":"Circulation"},{"key":"2024041812175402100_zwae004-B2","doi-asserted-by":"crossref","first-page":"c2442","DOI":"10.1136\/bmj.c2442","article-title":"An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study","volume":"340","author":"Collins","year":"2010","journal-title":"BMJ"},{"key":"2024041812175402100_zwae004-B3","first-page":"e649","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"2024041812175402100_zwae004-B4","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1056\/NEJM195705232562101","article-title":"Genes, the heart and destiny","volume":"256","author":"White","year":"1957","journal-title":"N Engl J Med"},{"key":"2024041812175402100_zwae004-B5","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41591-020-0800-0","article-title":"Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers","volume":"26","author":"Mars","year":"2020","journal-title":"Nat Med"},{"key":"2024041812175402100_zwae004-B6","doi-asserted-by":"crossref","first-page":"e003304","DOI":"10.1161\/CIRCGEN.120.003304","article-title":"An integrated polygenic tool substantially enhances coronary artery disease prediction","volume":"14","author":"Riveros-Mckay","year":"2021","journal-title":"Circ Genom Precis Med"},{"key":"2024041812175402100_zwae004-B7","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/jamacardio.2023.0857","article-title":"Cardiovascular disease risk assessment using traditional risk factors and polygenic risk scores in the Million Veteran Program","volume":"8","author":"Vassy","year":"2023","journal-title":"JAMA Cardiol"},{"key":"2024041812175402100_zwae004-B8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13073-021-00829-7","article-title":"Polygenic risk scores in the clinic: new perspectives needed on familiar ethical issues","volume":"13","author":"Lewis","year":"2021","journal-title":"Genome Med"},{"key":"2024041812175402100_zwae004-B9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41586-021-03243-6","article-title":"Improving reporting standards for polygenic scores in risk prediction studies","volume":"591","author":"Wand","year":"2021","journal-title":"Nature"},{"key":"2024041812175402100_zwae004-B10","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S2215-0366(22)00403-5","article-title":"Effect of polygenic risk for schizophrenia on cardiac structure and function: a UK Biobank observational study","volume":"10","author":"Pillinger","year":"2023","journal-title":"Lancet Psychiatry"},{"key":"2024041812175402100_zwae004-B11","doi-asserted-by":"crossref","first-page":"104383","DOI":"10.1016\/j.ebiom.2022.104383","article-title":"Prediction of type 2 diabetes using genome-wide polygenic risk score and metabolic profiles: a machine learning analysis of population-based 10-year prospective cohort study","volume":"86","author":"Hahn","year":"2022","journal-title":"EBioMedicine"},{"key":"2024041812175402100_zwae004-B12","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41588-018-0183-z","article-title":"Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations","volume":"50","author":"Khera","year":"2018","journal-title":"Nat Genet"},{"key":"2024041812175402100_zwae004-B13","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1161\/CIRCULATIONAHA.118.035658","article-title":"Whole-genome sequencing to characterize monogenic and polygenic contributions in patients hospitalized with early-onset myocardial infarction","volume":"139","author":"Khera","year":"2019","journal-title":"Circulation"},{"key":"2024041812175402100_zwae004-B14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.amjcard.2021.02.032","article-title":"Validation of an integrated risk tool, including polygenic risk score, for atherosclerotic cardiovascular disease in multiple ethnicities and ancestries","volume":"148","author":"Weale","year":"2021","journal-title":"Am J Cardiol"},{"key":"2024041812175402100_zwae004-B15","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1001\/jamacardio.2022.4466","article-title":"Predictive utility of a coronary artery disease polygenic risk score in primary prevention","volume":"8","author":"Marston","year":"2023","journal-title":"JAMA Cardiol"},{"key":"2024041812175402100_zwae004-B16","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/s41591-022-01767-6","article-title":"Development of a clinical polygenic risk score assay and reporting workflow","volume":"28","author":"Hao","year":"2022","journal-title":"Nat Med"},{"key":"2024041812175402100_zwae004-B17","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1186\/s13063-022-06734-7","article-title":"The SCRIPT trial: study protocol for a randomised controlled trial of a polygenic risk score to tailor colorectal cancer screening in primary care","volume":"23","author":"Saya","year":"2022","journal-title":"Trials"},{"key":"2024041812175402100_zwae004-B18","doi-asserted-by":"crossref","first-page":"100006","DOI":"10.1016\/j.gim.2023.100006","article-title":"Returning integrated genomic risk and clinical recommendations: the eMERGE study","volume":"25","author":"Linder","year":"2023","journal-title":"Genet Med"},{"key":"2024041812175402100_zwae004-B19","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S2213-2600(20)30101-6","article-title":"Chronic obstructive pulmonary disease and related phenotypes: polygenic risk scores in population-based and case-control cohorts","volume":"8","author":"Moll","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2024041812175402100_zwae004-B20","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S2215-0366(21)00253-4","article-title":"Post-partum psychosis and its association with bipolar disorder in the UK: a case-control study using polygenic risk scores","volume":"8","author":"Di Florio","year":"2021","journal-title":"Lancet Psychiatry"},{"key":"2024041812175402100_zwae004-B21","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1161\/CIRCULATIONAHA.115.020109","article-title":"Incorporating a genetic risk score into coronary heart disease risk estimates: effect on low-density lipoprotein cholesterol levels (the MI-GENES Clinical Trial)","volume":"133","author":"Kullo","year":"2016","journal-title":"Circulation"},{"key":"2024041812175402100_zwae004-B22","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13073-022-01117-8","article-title":"Patient and provider perspectives on polygenic risk scores: implications for clinical reporting and utilization","volume":"14","author":"Lewis","year":"2022","journal-title":"Genome Med"},{"key":"2024041812175402100_zwae004-B23","doi-asserted-by":"crossref","first-page":"e003459","DOI":"10.1161\/CIRCGEN.121.003459","article-title":"How communicating polygenic and clinical risk for atherosclerotic cardiovascular disease impacts health behavior: an observational follow-up study","volume":"15","author":"Wid\u00e9n","year":"2022","journal-title":"Circ Genom Precis Med"},{"key":"2024041812175402100_zwae004-B24","first-page":"e93","article-title":"Polygenic risk scores for cardiovascular disease: a scientific statement from the American Heart Association","volume":"146","author":"O'Sullivan","year":"2022","journal-title":"Circulation"},{"key":"2024041812175402100_zwae004-B25","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/biomet\/26.4.404","article-title":"The use of confidence or fiducial limits illustrated in the case of the binomial","volume":"26","author":"Clopper","year":"1934","journal-title":"Biometrika"},{"key":"2024041812175402100_zwae004-B26","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1161\/CIRCULATIONAHA.119.044770","article-title":"Polygenic risk scores and coronary artery disease: ready for prime time?","volume":"141","author":"Levin","year":"2020","journal-title":"Circulation"},{"key":"2024041812175402100_zwae004-B27","doi-asserted-by":"crossref","first-page":"482.e11","DOI":"10.1016\/j.amjmed.2016.11.021","article-title":"Clinical utility of a precision medicine test evaluating outpatients with suspected obstructive coronary artery disease","volume":"130","author":"Ladapo","year":"2017","journal-title":"Am J Med"},{"key":"2024041812175402100_zwae004-B28","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jcmg.2017.01.030","article-title":"The identification of calcified coronary plaque is associated with initiation and continuation of pharmacological and lifestyle preventive therapies: a systematic review and meta-analysis","volume":"10","author":"Gupta","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"2024041812175402100_zwae004-B29","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/jgc4.1078","article-title":"Racial and ethnic differences in knowledge and attitudes about genetic testing in the U.S.: systematic review","volume":"28","author":"Canedo","year":"2019","journal-title":"J Genet Couns"},{"key":"2024041812175402100_zwae004-B30","author":"Kapadia"},{"key":"2024041812175402100_zwae004-B31"}],"container-title":["European Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjpc\/advance-article-pdf\/doi\/10.1093\/eurjpc\/zwae004\/56254741\/zwae004.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/31\/6\/716\/57263492\/zwae004.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/31\/6\/716\/57263492\/zwae004.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T08:18:22Z","timestamp":1713428302000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjpc\/article\/31\/6\/716\/7577877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,19]]},"references-count":31,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,1,19]]},"published-print":{"date-parts":[[2024,4,18]]}},"URL":"https:\/\/doi.org\/10.1093\/eurjpc\/zwae004","relation":{},"ISSN":["2047-4873","2047-4881"],"issn-type":[{"value":"2047-4873","type":"print"},{"value":"2047-4881","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,4]]},"published":{"date-parts":[[2024,1,19]]}}}